Clinical Trials Sponsored by Institut Bergonie

Total 74452 results

Institut Bergonié
Fondation Bergonié

Recruiting

Circulating Tumor DNA After Neoadjuvant Chemotherapy (ALIENOR)

Breast Cancer

France
Institut Bergonié

Recruiting

Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery (MONIALC)

Ovarian Neoplasm

France
Institut Bergonié

Recruiting

Regional Central Database Recording of Chronic Myeloid Leukemia (LMC)

Chronic Myeloid Leukemia

France
Institut Bergonié

Active, not recruiting

Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients (OPTIMUNELUNG)

Non Small Cell Lung Cancer

France
Institut Bergonié

Completed

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (OMEGA)

Colorectal Cancer

France
Institut Bergonié

Completed

Efavirenz in Treating Patients With Metastatic Prostate Cancer (FAVE)

Prostate Cancer

France
Institut Bergonié

Completed

PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases (TEPARF)

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

France
Institut Bergonié

Completed

Ultrasound Liver Intraoperative Imaging With SonoVue® (ULIIS)

Liver Metastases From Colorectal Primary Cancer

France
Institut Bergonié

Completed

CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology (CAP'ONCO)

Cancer

France
Institut Bergonié

Completed

PET Enhanced CT Scan Performance in Cancer (COMBITEP)

Cancer Disease Progression
Institut Bergonié

Unknown

Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer (TEP Vessie)

Muscle Invasive Bladder Cancer

France
Institut Bergonié

Completed

Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines (PEPNATB)

Breast Cancer

France
Institut Bergonié

Completed

Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery (ROPAL 1)

Cancer | Postoperative Pain

France
Institut Bergonié

Completed

Administration of Ketamine to Prevent the Post-operative Pain (KETAMINE)

Breast Cancer | Postoperative Pain

France
Institut Bergonié

Completed

Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms (FCRVADS)

Upper Gingival Squamous Cell Carcinoma

France
Institut Bergonié

Recruiting

Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Management (OPTIMOVA)

Ovarian Carcinoma

France
Institut Bergonié

Recruiting

Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma (CRYOMUNE)

Lung Adenocarcinoma | Cryotherapy Effect

France
Institut Bergonié

Recruiting

Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study (COPE)

Colorectal Cancer | Non Small Cell Lung Cancer

France
Institut Bergonié

Recruiting

Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials (BIP)

Solid Tumor | Hematological Malignancy

France
Institut Bergonié

Completed

Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic (PRO-SERO-COV)

Sars-CoV2 | Serum; Disease

France
Institut Bergonié

Completed

Assessment of Cognitive Function After Surgery in Two Types of Anesthesia in Patients Operated for Breast Cancer (HYPNOSEIN)

Patients With Breast Cancer and Breast Surgery Requiring

France
Institut Bergonié

Completed

Efficacy of Delayed Coloanal Anastomosis for Medium and Lower Rectum Cancer Treatment. Phase 2 Clinical Trial (CASCADOR) (CASCADOR)

Medium and Lower Rectal Cancer

France
Institut Bergonié

Completed

Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer (MEDOR)

Pain | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

France
Institut Bergonié

Completed

Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure. (ESCALE)

Non-Hodgkin's Lymphoma | Solid Tumors

France
Institut Bergonié

Unknown

Bergonie Institute Breast Cancer Database

Breast Cancer
Institut Bergonié

Unknown

STUDY OF THE EXPRESSION OF CIRCULATING AND INTRA-TUMORAL CHEMOKINES IN PATIENTS WITH PROSTATE CANCER (CHEMOPROST)

Prostate Cancer

France
Institut Bergonié

Completed

Radiofrequency of Breast Cancers in Non Surgical Patients (RF SEIN)

Breast Cancer

France
Institut Bergonié

Completed

Intraoperative Nitrous Oxide and Postoperative Pain for Patients With Current Opioid Treatment (PROTOX)

Chronic Pain

France
Institut Bergonié

Completed

Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer. (ASE K SEIN)

Breast Cancer

France
Institut Bergonié

Recruiting

Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene (COCO)

PTEN Gene Mutation

France
Institut Bergonié

Not yet recruiting

Remote Monitoring for Ambulatory Care of Elderly Patients With Cancer (TS-PAC)

Cancer
Institut Bergonié

Recruiting

Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients (PIPER)

Soft Tissue Sarcoma Adult | Solitary Fibrous Tumors | Hemangioendothelioma | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Epithelioid Sarcoma | Desmoplastic Round Cell Tumor

France
Institut Bergonié

Completed

Health Literacy and Digital Health in Cancer Patients. (LICAPA)

Cancer

France
Institut Bergonié

Completed

A Public Health Intervention Program to Improve the Initial Management of Soft Tissue Sarcomas. (IPSSAR)

Sarcoma
Institut Bergonié

Completed

Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection, With or Without Neoadjuvant Chemotherapy. (ARF2003)

Colorectal Cancer

France
Institut Bergonié

Completed

Feasibility Study on the Contribution of Guided Puncture With Echoendoscopy (APOGEE)

Hypermetabolic Lymphadenopathy Mediastinum Lower, Posterior and Middle, Detected by PET-CT With 18F-FDG (PET)

France
Institut Bergonié

Completed

Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma (TOMOREP)

Liposarcoma

France
Institut Bergonié

Completed

PAZOPANIB Efficacy and Tolerance in Desmoids Tumors (DESMOPAZ)

Progressive Desmoids Tumors

France
Institut Bergonié

Completed

Efficacy and Safety of PD-0332991 in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (CYCLIGIST)

Advanced Gastrointestinal Stromal Tumors

France
Institut Bergonié

Completed

Trends in Modern Phase 1 Oncology Trials (Phase 1)

Cancer

France
Institut Bergonié

Unknown

MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii (MOLTHYSO)

Ovarian Cancer

France
Institut Bergonié

Completed

Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast (CINNAMOME)

Intraductal Carcinoma and Lobular Carcinoma in Situ

France
Institut Bergonié

Terminated

Erectile Rating During the Treatment of Rectal Cancers Localized (METEORR)

Rectal Cancer Stage I

France
Institut Bergonié

Completed

Hypercoagulability After Breast Cancer Surgery (EHC)

Breast Cancer | Blood Coagulation Disorders

France
Institut Bergonié

Terminated

Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer (AXIL95)

Breast Cancer

France
Institut Bergonié

Terminated

Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy (USF)

Breast Tumor

France
Institut Bergonié
Bayer

Recruiting

Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer (DARIUS)

Prostate Cancer

France
Institut Bergonié
Novartis

Terminated

Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response (AFR22)

Myeloid Leukemia, Chronic

France
Institut Bergonié
AstraZeneca

Recruiting

Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients (CIRCULAR)

Non Small Cell Lung Cancer | Advanced Solid Tumor

France
Institut Bergonié
Bayer

Completed

A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study (NTRK)

Metastatic Solid Tumors

France

3

Subscribe